Atlas Trials

Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation

Clinical trial NCT06560801 · RECRUITING

Trial details

NCT number
NCT06560801
Sponsor
University of Erlangen-Nürnberg Medical School
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Kidney Diseases
Start date
2023-07-28
Primary completion
2026-10-31
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.